PD-L1 Antikörper

Produktnummer ABIN7670003

Dieses Anti-PD-L1-Antikörper ist ein Maus Monoklonal-Antikörper zur Detektion von PD-L1 in FACS. Geeignet für Human.

Kurzübersicht für PD-L1 Antikörper (ABIN7670003)

Target: PD-L1 (CD274 (PD-L1))

Reaktivität: Human

Wirt: Maus

Klonalität: Monoklonal

Konjugat: Dieser PD-L1 Antikörper ist unkonjugiert

Applikation: Flow Cytometry (FACS)

Klon: 9F7

Produktdetails anti-PD-L1 Antikörper

Verwendungszweck: Purified Anti-Human CD274 Antibody[9F7]

Isotyp: IgG2a, kappa

Anwendungsinformationen

Applikationshinweise: Optimal working dilution should be determined by the investigator.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Konzentration: ≥ 1 mg/mL

Buffer: Phosphate buffered solution, pH 7.2, containing 0.05 % proclin 300.

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handhabung: avoid freeze / thaw cycles.

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Store at 4°C valid for 12 months or -20°C valid for long term storage, avoid freeze / thaw cycles.

Haltbarkeit: 12 months

Details zu PD-L1

Target: PD-L1 (CD274 (PD-L1))

Andere Bezeichnung: CD274

Hintergrund: PDL,B7H,PD-L,PD1L,Programmed cell death 1 ligand,PDCD1L,PDCD1LG,B7-H,B7H1,PDL1,PD-L1,PDCD1L1,PDCD1LG1,CD274,B7-H1,B7 homolog 1,CD274 Molecule,PDCD1 ligand 1,Programmed death ligand 1,PD1L1,Programmed cell death 1 ligand 1, PDL1, PD-L1,B7-H,B7H1,CD274 Molecule,PDCD1L1,PDCD1LG1,B7 H,B7 H1,CD 274,CD274 antigen,MGC142294,MGC142296,OTTHUMP00000021029,PD L1,PDL 1,RGD1566211,Human B7 homolog 1 (B7-H1), also called programmed death ligand 1 (PD-L1) and programmed cell death 1 ligand 1 (PDCD1L1), is a member of the growing B7 family of immune proteins that provide signals for both stimulating and inhibiting T cell activation. Other family members include B7-1, B7-2, B7-H2, PDL2 and B7-H3. B7 proteins are members of the immunoglobulin (Ig) superfamily.

UniProt: Q9NZQ7

Pathways: Cancer Immune Checkpoints